LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

LLY

1,030.06

+0.68%↑

JNJ

243.75

+1.91%↑

ABBV

224.33

+1.19%↑

NVS

160.78

+0.8%↑

MRK

120.94

+2.06%↑

Search

Merit Medical Systems Inc

Open

BrancheGesundheitswesen

80.4 0.4

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

79.65

Max

81.53

Schlüsselkennzahlen

By Trading Economics

Einkommen

-4.8M

28M

Verkäufe

1.7M

384M

KGV

Branchendurchschnitt

41.451

121.746

Gewinnspanne

7.225

Angestellte

7,400

EBITDA

-4.4M

80M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+30.31% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

24. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-108M

4.8B

Vorheriger Eröffnungskurs

80

Vorheriger Schlusskurs

80.4

Nachrichtenstimmung

By Acuity

50%

50%

149 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Merit Medical Systems Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Feb. 2026, 23:47 UTC

Heiße Aktien

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11. Feb. 2026, 22:59 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Grab Holdings to Buy U.S.-Based Stash Financial

11. Feb. 2026, 23:54 UTC

Ergebnisse

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11. Feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11. Feb. 2026, 23:49 UTC

Ergebnisse

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11. Feb. 2026, 23:45 UTC

Ergebnisse

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11. Feb. 2026, 23:42 UTC

Ergebnisse

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11. Feb. 2026, 23:41 UTC

Ergebnisse

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11. Feb. 2026, 23:40 UTC

Ergebnisse

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11. Feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11. Feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11. Feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11. Feb. 2026, 22:58 UTC

Ergebnisse

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11. Feb. 2026, 22:57 UTC

Ergebnisse

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11. Feb. 2026, 22:54 UTC

Ergebnisse

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11. Feb. 2026, 22:53 UTC

Ergebnisse

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:23 UTC

Ergebnisse

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11. Feb. 2026, 22:19 UTC

Ergebnisse

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11. Feb. 2026, 22:16 UTC

Ergebnisse

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Peer-Vergleich

Kursveränderung

Merit Medical Systems Inc Prognose

Kursziel

By TipRanks

30.31% Vorteil

12-Monats-Prognose

Durchschnitt 105.33 USD  30.31%

Hoch 122 USD

Tief 90 USD

Basierend auf 9 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Merit Medical Systems Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

9 ratings

8

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

95.585 / 96.35Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

149 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat